Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand name Mounjaro) and chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity (under the brand name Zepbound)
Samms RJ, Sloop KW, Gribble FM, et al
It is effective for both the face and body, making it a versatile option for patients dealing with loose skin after Semaglutide in multiple areas
Chronic, high-dose use without breaks poses a greater risk
This long shelf life makes bacteriostatic water a great choice for reconstituting peptides and other sensitive compounds
Laboratory studies have demonstrated that GLP-1 receptor activation can reduce the production of pro-inflammatory cytokines, including tumour necrosis factor-alpha (TNF-), interleukin-6 (IL-6), and interleukin-1 beta (IL-1)
